Sheng Zhou

Dr. Sheng Zhou

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JZJiarui Zhang
Jiarui Zhang
SZSheng Zhou
Sheng Zhou
YFYujie Feng
Yujie Feng
HLHuaijin Liu
Huaijin Liu
CLChengcheng Li
Chengcheng Li
The uneven distribution of human resources for health (HRH) in China, particularly within the realm of traditional Chinese medicine (TCM), has long posed a significant challenge. Although prior studies have examined regional disparities in overall HRH, limited research has specifically addressed the spatial and temporal dynamics of HRH in TCM and their underlying determinants. This study employs a multiscale geographically weighted regression (MGWR) model to explore the spatial and temporal dynamics of HRH in TCM across 31 Chinese provinces from 2008 to 2021. MGWR allows each explanatory variable to operate at its optimal spatial scale, capturing localized patterns of spatial heterogeneity. The results reveal that although HRH in TCM has generally increased over time, substantial disparities persist, with eastern and central regions exhibiting a higher degree of resource agglomeration while western regions continue to lag behind. Economic factors such as wage income, the number of TCM institutions, and education funding emerge as the most significant and spatially heterogeneous determinants. These localized effects suggest that region-specific policy interventions are needed—such as financial incentives and infrastructure support for underserved western regions, and institutional integration and quality standardization in eastern areas—reflecting the differentiated roles and development contexts of TCM across regions. By leveraging the advantages of MGWR in capturing multiscale spatial patterns, this study provides empirical evidence to support more targeted and sustainable planning for HRH in TCM development. Enhancing the accessibility of TCM services not only addresses current regional imbalances but also strengthens the healthcare system’s capacity to respond to the needs of an aging population and future public health emergencies. The findings offer valuable insights for policymakers aiming to improve health equity in China and may inform similar efforts in other countries facing spatial disparities in traditional medicine resources.

18 April 2026 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
KCKeneng Cai
Keneng Cai
RXRun Xia
Run Xia
MXMengyao Xu
Mengyao Xu
WCWanying Chen
Wanying Chen
WCWenli Cai
Wenli Cai
JLJianming Liang
Jianming Liang
Triple-negative breast cancer (TNBC) remains a formidable clinical challenge because of its high aggressiveness, metastatic potential, and lack of effective therapeutic options. In this study, we developed an injectable multifunctional hydrogel, MND-ART-GEL, by encapsulating immunostimulatory manganese urate (MnUA), the chemotherapeutic agent doxorubicin (DOX), and an artemisinin derivative, artesunate (ART), within a thermosensitive Pluronic F127 matrix. Uric acid crystals (MSU) and manganese ions (Mn2+) were coordinated and assembled into manganese urate (MnUA). The MSU-Mn2+ system exhibits a synergistic immunoactivating effect by combining the DAMP-like immune stimulation of MSU with the STING pathway activation ability of Mn2+. Owing to its simple chemical composition, low cost, and accessibility, this combination offers a more practical and scalable alternative to conventional synthetic immune agonists. ART synergizes with DOX to exert potent antitumor effects. MND-ART-GEL synergistically elevated intracellular ROS levels, inducing oxidative stress, mitochondrial damage, and subsequent tumor cell apoptosis, immunogenic cell death (ICD), and exposure to immune markers such as MHCI and Fas. Moreover, MND-ART-GEL downregulated STAT3 expression, thereby suppressing tumor cell invasion and migration. In orthotopic and postsurgical TNBC mouse models, MND-ART-GEL significantly inhibited tumor growth and recurrence, remodeled the immunosuppressive tumor microenvironment, enhanced CD8+ T-cell infiltration, dendritic cell maturation, and M1 macrophage polarization, reduced PD-1/PD-L1 expression on CD8+ T cells, and promoted the secretion of immune-related cytokines. This study presents a localized drug delivery strategy that integrates chemotherapy, immune modulation, and multitarget synergy, offering a promising approach to overcome therapeutic resistance and reduce recurrence in TNBC.

Verified
Journal Article
Open access
PDF file
SZSheng Zhou
Sheng Zhou
LYLinxin Yu
Linxin Yu
JLJianming Liang
Jianming Liang
WXWei Xie
Wei Xie
GLGuoming Li
Guoming Li
YCYinhuan Chen
Yinhuan Chen
Background: Recent setbacks in malaria control in Comoros demand a reassessment of its evolving epidemiology. Methods: Using the Global Burden of Disease (GBD) Study 2021 data, we analyzed malaria trends from 2010 to 2021, stratified by sex. We quantified the contributions of demographic and epidemiological factors to these trends and identified risk factors for malaria-related disability-adjusted life years (DALYs). Results: From 2010 to 2021, malaria cases, deaths, and DALYs in Comoros fell by −90.22%, −94.44%, and −94.88%; and the corresponding age-standardized rates declined with EAPCs of −18.70% (95% CI: −33.77 to −0.20), −23.89% (95% CI: −36.58 to −8.66), and −24.49% (95% CI: −36.88 to −9.66), with steeper declines in males. Nevertheless, all indicators increased in 2018 and again in 2021. In sub-Saharan Africa, only cases increased, while other metrics declined slightly. In Comoros, incidence shifted mainly to adults ≥25 years, unlike sub-Saharan Africa, where children < 5 years were most affected. Population growth drove increases in cases, deaths and DALYs, whereas epidemiological shifts had the opposite effect. Child underweight was the leading risk factor for malaria DALYs. Conclusions: Existing interventions can achieve malaria control in Comoros; however, rebounds in 2018 and 2021 highlight the need to identify and address drivers of resurgence.

12 March 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
SZSheng Zhou
Sheng Zhou
JZJiarui Zhang
Jiarui Zhang
CLChengcheng Li
Chengcheng Li
Background: Malaria is a major public health issue in the Comoros. Analyzing the malaria burden will aid in designing prevention, control, and eradication strategies based on scientific evidence.Methods: We retrieved data from the 2021 Global Burden of Disease (GBD) database to assess the malaria burden in the Comoros in 2021, stratified by sex and age. The indicators used to measure this burden included the absolute numbers and rates of incidence, prevalence, and mortality, as well as disability-adjusted life years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs). Decomposition analysis was used to quantify the contributions of demographic aging, population growth, and epidemiological changes to the malaria burden from 1990 to 2021. Joinpoint regression analysis was employed to examine temporal trends in the malaria burden over this period.Results: In 2021, females, particularly those under 40, had a higher overall malaria burden than males, except for the age-standardized incidence rate (ASIR) and the age-standardized mortality rate (ASMR). Individuals under 30 years of age experienced approximately 52% of new malaria episodes, 68% of prevalent cases, and 62% of YLDs. Children under 5 and those aged 15 to 30 accounted for about 41% of malaria-related deaths, 54% of YLLs, and 53% of DALYs. Between 1990 and 2021, the malaria burden in the Comoros declined substantially, with age-standardized incidence (ASIR), prevalence (ASPR), mortality (ASMR), and DALY rates (ASDR) decreasing by over 85%. Decomposition analysis indicated that epidemiological changes played a pivotal role in reducing disease burden. Over the past 32 years, the average annual percentage change (AAPC) in the ASPR was statistically significant at −7.60% (t = −2.68, p < 0.05). Moreover, the annual percentage change (APC) in ASIR and ASPR showed the most significant decline from 2012 to 2015, with APCs of −70.47% (t = −3.01, p < 0.05) and − 66.55% (t = −14.94, p < 0.05), respectively.Conclusion: This study indicates that women under 40, school-aged children, and adults under 30 in the Comoros bear a higher malaria burden. Although current malaria control measures are effective, achieving a malaria-free status will require integrated strategies.

30 May 2026 in Chemical Engineering Journal
Verified
Journal Article
Closed access
WCWanying Chen
Wanying Chen
XLXinyu Liu
Xinyu Liu
TGTiantian Guo
Tiantian Guo
KCKeneng Cai
Keneng Cai
WCWenli Cai
Wenli Cai
JLJianming Liang
Jianming Liang

11 January 2026 in International Journal of Pharmaceutics: X
Verified
Journal Article
Open access
CYChuyi Yu
Chuyi Yu
XLXiaobo Li
Xiaobo Li
KCKeneng Cai
Keneng Cai
WJWeichi Jiang
Weichi Jiang
WCWanying Chen
Wanying Chen
JLJianming Liang
Jianming Liang
Owing to the emergence of drug resistance and the lack of effective vaccines, malaria continues to seriously harm the physical and mental health of a multitude of individuals, warranting the need to explore new antimalarial strategies. In this study, we developed allicin-based biomimetic nanoparticles of the erythrocyte membrane (PECm-Allicin@LM) through a sonication method for the delivery of lumefantrine (LM), a hydrophobic antimalarial drug. PECm-Allicin@LM showed regular spherical morphology with a mean diameter of 120 nm and retained most of the major proteins on the erythrocyte membrane. PECm-Allicin@LM was stable and sustained the release of LM. Flow cytometry analysis showed that PECm-Allicin@LM could deliver LM to Plasmodium-infected erythrocytes to kill the parasite. The nanoparticles, disguised as erythrocytes, could trap merozoites and competitively inhibit them from repeatedly infecting normal erythrocytes. Allicin in the nanoparticles not only dissolved LM but also disrupted the mitochondrial function of malaria parasites, working together to combat malaria and improve the immune dysfunction caused by malaria. Giemsa staining was performed to determine the infection rate in PbANKA-infected mice. In Plasmodium berghei ANKA strain-infected ICR mice, PECm-Allicin@LM significantly reduced infection rates, prolonged survival time, and attenuated Plasmodium-induced weight loss, anemia, and organ injury. Overall, these nanoparticles combine the advantages offered by the erythrocyte membrane, allicin, and LM to effectively combat malaria, representing a new antimalarial strategy targeting multiple pathways.